Clinical Pathology
2025 Symposium
April 22, 2025
Towsley Dow Auditorium & Lobby
We invite you to attend the 13th Clinical Pathology Symposium! A continuing education and networking event sponsored by the Department of Pathology. Michigan Medicine Department of Pathology is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Science & Sustainability
For a sustainable future, science and sustainability must work together. Scientific advancements drive sustainable technologies and solutions to reduce waste, energy use, and resource depletion. Sustainability ensures that progress protects ecosystems, conserves biodiversity, and supports equity. Together, science provides the tools, and sustainability ensures they are used responsibly for the planet’s long-term health.
Learn more about Making an Impact.
Schedule
8:30 - 9:30 am
Check-In & Continental Breakfast
9:30 - 10:30 am
Sustainability in Laboratories and Beyond
Sustainability at U-M is driven by university-wide goals centered around reducing the carbon impact of operations and creating a culture of sustainability. Laboratories play a large role in the emissions and waste produced on campus so there is potential for improvement. There are lab-focused programs at U-M that research staff can get involved with including a sustainability certification and specialty recycling programs. There are also opportunities beyond the lab to reduce environmental impact such as composting, sustainable commuting, and low-carbon food choices. This talk will explore some of the existing programs that offer U-M community members the opportunity to improve while also highlighting sustainability champions having already made great progress. Basic level of instruction, 1 contact hour. (PATH-47100)
Event Objectives:
- Describe the current U-M sustainability goals and the relevant data driving those goals
- Identify the existing programs and resources targeting laboratory, general campus, and Michigan Medicine sustainability
- Recognize the progress made by Clinical Pathology sustainability champions and encourage others to translate that to their own spaces

Alexandria Galens, BS
Program Coordinator
Office of Campus Sustainability
Alexandria Galens, BS
Program Coordinator
Office of Campus Sustainability
Having graduated from the University of Michigan with degrees relating to the environment, biology, and psychology; Alexandria joined U-M’s Office of Campus of Sustainability's Waste, Reducation, and Engagement team. She specializes in sustainable labs and manages programs including an internal Sustainable Lab Certification Program, a three-part Lab Reuse Program, the International Freezer Challenge, and specialty recycling programs. She is passionate about working one-on-one with researchers and finding creative solutions to complex problems.

Christopher Victory, BSME
Senior Sustainability Consultant
University of Michigan Health
Christopher Victory, BSME
Senior Sustainability Consultant
University of Michigan Health
With a robust fifteen-year record specific to healthcare sustainability and over twenty-five years of experience in facilities-based healthcare engineering, Christopher’s unique background empowers him to lead initiatives that drive sustainability while addressing the complex engineering challenges of healthcare facilities. Christopher holds a Bachelor of Science degree in Mechanical Engineering" (BSME) from Michigan Technological University and is a licensed Professional Engineer (PE) and Certified Energy Manager (CEM).

Stephanie Peters, MS
Sustainability Project Manager
University of Michigan Health
Stephanie Peters, MS
Sustainability Project Manager
University of Michigan Health
Before joining the University of Michigan Health, Stephanie spent three years working as a Senior Sustainability Analyst in the packaging industry. She received her Master of Science degree from the University of Michigan School for Environment and Sustainability.
10:30 - 11:00 am
Exhibits
11:00 am - 12:00 pm
Elemental Toxicity: Case Files from the Metals Lab
Exposure to heavy metals is common because of environmental contamination of air, water, and soil as well as accumulation in food, tobacco, herbal medicines, and occupational contact. Toxic effects, when they occur, may present with non-specific symptoms, resulting in a very large differential for clinicians to consider. Arsenic, lead, and mercury are all among the top ten substances priority list targeted by the Agency for Toxic Substances and Disease Registry (ATSDR). In this presentation, clinical case studies will be used to illustrate common signs and symptoms along with supportive laboratory data to help identify and diagnose heavy metal toxicity. Analysis of Beethoven’s hair will also be discussed. Intermediate level of instruction, 1.0 contact hour. (PATH-47200)
Event Objective:
- Recognize and correlate the physical, clinical laboratory, and anatomic findings related to occupational, environmental, and/or intentional toxic element exposure.
- Identify and correctly interpret the appropriate laboratory tests being used to detect and/or monitor exposure for several toxic elements.
- List appropriate treatment strategies for heavy metal toxicity.

Paul J. Jannetto, PhD, DABCC, FADLM, MT(ASCP)
Professor
Department of Laboratory Medicine and Pathology and Consultant
Mayo Clinic (Rochester, MN)
Paul J. Jannetto, PhD, DABCC, FADLM, MT(ASCP)
Professor
Department of Laboratory Medicine and Pathology and Consultant
Mayo Clinic (Rochester, MN)
A Professor in the Department of Laboratory Medicine and Pathology and a Consultant at the Mayo Clinic (Rochester, MN), where he serves as the Co-Director for the Clinical Mass Spectrometry Laboratory, Clinical and Forensic Toxicology Laboratory, and the Metals Laboratory. He also serves as the Vice-Chair of Practice-Laboratory Medicine for the Department of Laboratory Medicine & Pathology. Previously, he earned his BS in Clinical Laboratory Science from the University of Wisconsin-Milwaukee and worked as a Medical Technologist for Medical Science Laboratories before entering graduate school. He then earned a Ph.D. in Pharmacology and Toxicology at the Medical College of Wisconsin. He is board-certified by the American Board of Clinical Chemistry and American Society for Clinical Pathology. His clinical and scientific interests are centered on Clinical & Forensic Toxicology, Therapeutic Drug Monitoring, Controlled Substance Monitoring, and Elemental Analysis. Dr. Jannetto is actively involved in the Association for Diagnostics & Laboratory Medicine (ADLM) where he has served on numerous positions at the national level as a member of the Governance Review Advisory Taskforce, NACB Board of Directors, and AACC Board of Directors. He was also just elected as the President-Elect of ADLM (formerly AACC) and his term starts August 2024. Dr. Jannetto is also a member of the American Academy of Pain Medicine, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Forensic Toxicologists, The International Association of Forensic Toxicologists, and was the President of the Midwest Association for Toxicology and Therapeutic Drug Monitoring. He has over 100 peer-reviewed publications, 19 book chapters, and over 90 abstracts/presentations at various national meetings.
12:00 - 1:00 pm
Exhibits & Lunch
1:00 pm - 2:00 pm
Square Peg, Round Hole: The FDA and You!
Join us for an exploration of the FDA's evolving role in regulating laboratory-developed procedures. From its historical claims of authority to the intricate details of the upcoming phase-out of enforcement discretion, this talk will equip you with the knowledge to navigate these significant changes and understand their major impact on laboratories, healthcare providers, and patients. Intermediate level of instruction, 1.0 contact hour. (PATH-47300)
Event Objective:
- Describe the history of the FDA's claims to authority to regulate laboratory-developed procedures
- Enumerate the steps to the 4-year phase-out of enforcement discretion and the exclusions to the FDA ruling
- Analyze the impact of the FDA ruling

Annette Kim, MD, PhD
Professor & Director, Molecular and Genomic Pathology
Henry Clay Bryant Professor of Pathology
Michigan Medicine
Annette Kim, MD, PhD
Professor & Director, Molecular and Genomic Pathology
Henry Clay Bryant Professor of Pathology
Michigan Medicine
Dr. Kim’s research program has focused on the study of hematolymphoid malignancies, including miRNAs in myelodysplastic syndromes, myeloid and lymphoid mutational patterns, and test utilization management. She has served as a member of Molecular Oncology Committee and is currently Vice-Chair of the Personized Healthcare Committee for College of American Pathologists. She is also the Chair of the ASH Precision Medicine committee and Program Chair-Elect for the Association for Molecular Pathology. In 2019, Dr. Kim was awarded the CAP Public Service Award.
Make an Impact
Find more to learn about sustainability and how you can be involved by visiting more of our exhibits this year.
Blood Stem Cell Registry
At NMDP, we believe each of us holds the key to curing blood cancers and disorders. With the help of blood stem cell donors from the world’s most diverse registry, we’re expanding access to treatment so that every patient can receive their life-saving cell therapy. Visit our table during the Symposium this year to learn more about the blood stem cell registry and see if you’re eligible to join!
Learn more about them by visiting network.nmdp.org.
Zero Waste Event
An event that aims to reduce waste, recycle, and compost as much as possible to divert waste from the landfill. Zero waste events are an important contribution to U-M’s waste reduction goal.
Learn more at ocs.umich.edu.
Planet Blue
Climate change is the issue of our time, and combating the climate crisis is global society’s greatest current challenge. A number of technological, business, and policy hurdles must be overcome to ensure the future vitality of both the natural and built environments.
Learn more at planetblue.umich.edu.

Karen Barron
Allied Health Education Program Manager
(734) 232-6751
karbarro med.umich.edu
Lauren Branson
Pathology Administration
Anastazia Hartman
Pathology Communications
Kristina Martin
Clinical Pathology Operations Director
Amanda Martinez
Pathology Allied Health Education
Lynn McCain
Pathology Communications
Kamran Mirza
Professor and Director of the Division of Education
Andrea Parkinson
Histocompatibility
Andrew Szczembara
Point of Care Testing
Brent Temple
Pathology Informatics & Communications
Carol Young
Microbiology